sequence,length,provide,formula,molecular_weigth,charge,charge_density,isoelectric,inestability,aromaticity,aliphatic_index,hydrophobic_ratio,hydrophobicity_profile,hydrophobic_profile,inhibition_IC50,inhibition_unit,name_peptide,source,host,assay,PMID/DOI,categorized_IC50
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNSF,36,DB_HIV,C194 H294 N50 O64,4350.73,-3.898,-0.0008959416,3.9633789063,65.5305555556,0.1111111111,89.4444444444,0.2777777778,0.0012105514,0.0018332996,15.629561016197286,nM,T706,gp41,CEM,RT production,US6861059,Class I
YTSLIHSLIEEPQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C204 H301 N51 O62,4459.9,-3.898,-0.0008740106,3.9633789063,62.65,0.1388888889,89.4444444444,0.2777777778,0.0021048784,0.0005847535,446.0,nM,T-20S138P,Enfuvirtide,HeLa,MAGI assay,19073606,Class III
YTSLIHSLIEESQNQQEKNEQELLELDKWASLANWF,36,DB_HIV,C194 H294 N50 O63,4334.73,-3.898,-0.0008992486,3.9633789063,52.644444444399994,0.1111111111,92.22222222219999,0.3055555556,0.0023445098,0.0009951154,0.2306948760361084,nM,T96,gp41,CEM,RT production,US6861059,Class II
ESQNQQEKNEQELLELDKWASLWNWFNITNWLWLIK,36,DB_HIV,C212 H310 N54 O60,4575.07,-1.997,-0.0004364961,4.0834960938,56.54444444439999,0.1666666667,89.4444444444,0.2777777778,0.0524757667,0.0089750401,218.5758906421104,nM,T630,gp41,CEM,RT production,US6861059,Class III
RPRLSHKGPMPF,12,DB_HIV,C64 H104 N22 O13 S1,1421.72,4.0939999999999985,0.0028796106,12.130859375,77.975,0.0833333333,32.5,0.25,0.1723265306,-0.0356849779,44312.52285963482,nM,Apelin-12 ,Apelin,NP-2/CD4,Immunofluorescence,10802050,Class III
LAAIPMSIPPEVKFNKPFVF,20,DB_HIV,C110 H170 N24 O24 S1,2244.75,1.997,0.0008896314,9.83984375,59.4,0.15,97.5,0.55,-0.056395604400000014,0.0209400115,100000.0,nM,A2,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
EINNYTSLIHSLIEESQNQQEKNEQELLELDKWASL,36,DB_HIV,C186 H294 N50 O66,4286.64,-4.896,-0.0011421533,3.8728027344,60.875,0.0555555556,100.27777777780001,0.2777777778,-0.0154279358,-0.0015123845,394.2481757273762,nM,T643,gp41,CEM,RT production,US6861059,Class III
YTSLIHSLIEERQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C205 H306 N54 O62,4518.97,-2.898,-0.0006412966000000001,4.2170410156,57.3,0.1388888889,89.4444444444,0.2777777778,0.0096821866,0.0039810009,362.0,nM,T-20S138Q,Enfuvirtide,HeLa,MAGI assay,19073606,Class III
WQTWERQVDNITQTISKALEEAQIQNEKNMYELQKLNQWDIFSNWF,46,DB_JAH,C259 H385 N69 O78 S1,5745.33,-1.998,-0.0003477607,4.1611328125,25.652173913000002,0.152173913,70.0,0.2826086957,0.007420396700000002,-0.0090414299,0.42,nM,V2o,,PM1 human T cell,,,Class II
YTSLIHSLIEESQNQQEKNEQELLELNKWASLWNWF,36,DB_HIV,C202 H300 N52 O62,4448.87,-2.898,-0.0006514014,4.1491699219,71.5861111111,0.1388888889,89.4444444444,0.2777777778,0.0034263467,0.0013550274,5.619404477991041,nM,T213,gp41,CEM,RT production,US6861059,Class II
LEAIAMSIPPEVKFNKPFVF,20,DB_HIV,C110 H170 N24 O26 S1,2276.75,0.998,0.00043834410000000016,6.875,64.61,0.15,97.5,0.55,-0.0532119309,0.0112282731,23500.0,nM,A5,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
YTSLIHSLIEESQNQQEKNEQELLEFDKWASLWNWF,36,DB_HIV,C205 H297 N51 O63,4483.87,-3.898,-0.0008693383,3.9633789063,66.0777777778,0.1666666667,78.6111111111,0.2777777778,0.0033062133,0.0016713791,0.11151081543398894,nM,T703,gp41,CEM,RT production,US6861059,Class II
LEAAPMSIPPEVKFNKPFVF,20,DB_HIV,C109 H166 N24 O26 S1,2260.71,0.998,0.0004414542,6.875,70.47,0.15,78.0,0.5,-0.0363516484,0.0221246732,100000.0,nM,A4,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
YTSLIHSLIEEHQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C205 H301 N53 O62,4499.92,-3.799,-0.0008442372,4.2133789063,49.855555555600006,0.1388888889,89.4444444444,0.2777777778,0.0036087717,0.0019789664,210.0,nM,T-20S138H,Enfuvirtide,HeLa,MAGI assay,19073606,Class III
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNAF,36,DB_HIV,C194 H294 N50 O63,4334.73,-3.898,-0.0008992486,3.9633789063,65.5305555556,0.1111111111,92.22222222219999,0.3055555556,0.0026343556,0.001436032,9.91987966955266,nM,T95,gp41,CEM,RT production,US6861059,Class II
WEEWDKKIEEYTKKIEELIKKS,22,DB_JAH,C132 H207 N31 O39,2852.25,0.003,1.0518012095713899e-06,4.8837890625,67.8181818182,0.13636363640000002,70.9090909091,0.1818181818,0.0254831933,0.0132477875,54.58,nM,SC22,,TZM-bl,,,Class I
YGGIKKEIEAIKKEQEAIKKKIEAIEKEIEA,31,DB_HIV,C160 H275 N41 O49,3557.16,1.005,0.0002825288,7.125,78.7741935484,0.0322580645,100.96774193549999,0.3548387097,0.0024956044,0.0022598423000000003,26.000000000000004,nM,Izm,gp41,293T,Luciferase assay,11572974,Class I
INNYTSLIHSLIEESQNQQEKNEQELLELDKWASL,35,DB_HIV,C181 H287 N49 O63,4157.52,-3.898,-0.0009375782,3.9633789063,56.825714285699995,0.0571428571,103.14285714290001,0.2857142857,-0.0167945109,-0.0014645986,55.32144162866325,nM,T622,gp41,CEM,RT production,US6861059,Class I
YTSLIHSLIEEIQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C205 H305 N51 O62,4475.94,-3.898,-0.0008708785,3.9633789063,57.3,0.1388888889,100.27777777780001,0.3055555556,-0.0015970126,-0.002987967,0.5,nM,T-20S138I,Enfuvirtide,HeLa,MAGI assay,19073606,Class II
WEEWDKKIEEYTKKIEELIKKSQNQQIDL,29,DB_JAH,C167 H264 N42 O52,3692.15,-0.997,-0.0002700324,4.5395507813,64.5448275862,0.1034482759,80.6896551724,0.2068965517,0.0017518351,-0.0115925673,1.6,nM,WQ-IDL,,MT-2,,,Class II
WQQWERQVRFLDANITKLLEEAQIQQEKNMYELQELDKWASLWNWF,46,DB_JAH,C271 H399 N71 O75 S1,5883.58,-1.996,-0.0003392492,4.2766113281,54.9304347826,0.1739130435,80.652173913,0.3260869565,0.0098093005,-0.0061198946,4.9,nM,C46,,PM1 human T cell,,,Class II
IHSLIEESQNQQEKNEQELLELDKWASLWNWFNITN,36,DB_HIV,C198 H297 N53 O63,4427.81,-3.897,-0.0008801191,3.9633789063,73.0388888889,0.1111111111,89.4444444444,0.2777777778,0.0313847132,0.0061556767,24.84298106738997,nM,T636,gp41,CEM,RT production,US6861059,Class I
YTSLIHSLIQQSQNQQQKNQQQLLQLDKWASLWNWF,36,DB_HIV,C202 H305 N57 O57,4443.95,2.094,0.0004712024,9.583984375,60.5555555556,0.1388888889,89.4444444444,0.2777777778,0.0032661688,0.0010811952,225.02503403503638,nM,T216,gp41,CEM,RT production,US6861059,Class III
LEAIPMSIPPEAKFNKPFVF,20,DB_HIV,C110 H168 N24 O26 S1,2274.73,0.998,0.0004387334,6.875,60.84,0.15,83.0,0.5,-0.0493124019,0.015746901599999998,10640.0,nM,A12,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
WQEWEQKITALLEQAQIQQEKNEYELQKLDKWASL WEWF,40,DB_HIV,,,-2.995,,4.1003417969,,0.175,75.75,0.275,,,,nM,1249,Synthetic,CEM4,MAGI/cMAGI infectivity assay,17640899,Class I
MTWQEWEKQVRYLEANISKSL,21,DB_JAH,C119 H184 N32 O34 S1,2639.0,0.999,0.0003785525,6.9375,28.0095238095,0.14285714289999998,74.2857142857,0.2857142857,0.0309795918,-0.0092270009,571.8,nM,P21_ROD,,TZM-bl,,,Class III
MTWEEWDKKIEEYTKKIEELIKKSEEQQKKN,31,DB_JAH,C177 H283 N45 O56 S1,3969.49,0.005,1.25960765740687e-06,5.01953125,74.4096774194,0.0967741935,50.322580645200006,0.1612903226,-0.0161351648,-0.007764931999999999,0.43,nM,MT-SC29,,TZM-bl,,,Class II
YTSLIHSLIEESQNQQEKNEQELLQLDKWASLWNWF,36,DB_HIV,C202 H300 N52 O62,4448.87,-2.899,-0.0006516261,4.0803222656,71.7055555556,0.1388888889,89.4444444444,0.2777777778,0.0026543779,0.0015883794,2.247761791196416,nM,T98,gp41,CEM,RT production,US6861059,Class II
WEEWDKKIEEYTKKIEELIKKS ,23,DB_JAH,C132 H207 N31 O39,2852.25,0.003,1.0518012095713899e-06,4.8837890625,67.8181818182,0.13636363640000002,70.9090909091,0.1818181818,0.0254831933,0.0132477875,51.3,nM,SC22EK,,TZM-bl,,,Class I
YTSLIHSLIEESQNQQEKNEQELLELDKPASLWNWF,36,DB_HIV,C196 H296 N50 O63,4360.76,-3.898,-0.0008938809,3.9633789063,70.0805555556,0.1111111111,89.4444444444,0.2777777778,-0.0002510726,-0.0007411086,116.95209091993138,nM,T704,gp41,CEM,RT production,US6861059,Class III
YTSLIHSLIEEVQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C204 H303 N51 O62,4461.91,-3.898,-0.0008736169,3.9633789063,51.95,0.1388888889,97.5,0.3055555556,-0.0007293819000000001,-0.0021424445,0.4,nM,T-20S138V,Enfuvirtide,HeLa,MAGI assay,19073606,Class II
YTSLIHSLIEESQNLQEKNEQELLELDKWASLWNWF,36,DB_HIV,C203 H302 N50 O62,4434.89,-3.898,-0.0008789395,3.9633789063,68.45,0.1388888889,100.27777777780001,0.3055555556,-6.41983155887448e-05,-0.00031036700000000003,0.6764542074324278,nM,T701,gp41,CEM,RT production,US6861059,Class II
LEAIPMSIPPEVKFNKPAVF,20,DB_HIV,C106 H168 N24 O26 S1,2226.69,0.998,0.0004481989,6.875,59.4,0.1,97.5,0.5,-0.0521569859,0.0074945153,100000.0,nM,A18,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
YTSLIHSLIEESQQQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C203 H301 N51 O63,4463.89,-3.898,-0.0008732294,3.9633789063,75.44444444439999,0.1388888889,89.4444444444,0.2777777778,0.0031126649,0.0012737589,0.6720595713604053,nM,T212,gp41,CEM,RT production,US6861059,Class II
YTSLIHSLIEESQNQQEKNEQQLLELDKWASLWNWF,36,DB_HIV,C202 H300 N52 O62,4448.87,-2.899,-0.0006516261,4.0803222656,62.65,0.1388888889,89.4444444444,0.2777777778,0.0028012077,0.001463211,0.4495523582392833,nM,T97,gp41,CEM,RT production,US6861059,Class II
QKEGLHYTCSSHFPYSQYQF,20,DB_HIV,C112 H153 N29 O32 S1,2449.67,1.125,0.0004592455,7.232421875,43.39,0.25,19.5,0.2,0.0058178964000000005,-0.0196780361,237000.0,nM,3,CCR5,TZM-bl,Neutralization Assay,22403408,Class III
YTSLIHSLIEEMQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C204 H303 N51 O62 S1,4493.98,-3.898,-0.0008673826,3.9633789063,49.855555555600006,0.1388888889,89.4444444444,0.3055555556,0.0006009852,-0.0008540286,0.7,nM,T-20S138M,Enfuvirtide,HeLa,MAGI assay,19073606,Class II
SLIEESQNQQEKNEQELLELDKWASLWNWFNITNWL,36,DB_HIV,C203 H300 N52 O63,4476.88,-3.996,-0.0008925859,3.6884765625,70.15833333329999,0.1388888889,89.4444444444,0.2777777778,0.0424671858,0.0086354593,123.74689515912868,nM,T634,gp41,CEM,RT production,US6861059,Class III
YTSLIHSLIEEGQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C201 H297 N51 O62,4419.83,-3.898,-0.0008819344,3.9633789063,51.95,0.1388888889,89.4444444444,0.2777777778,0.0010637216,-0.000408875,1.3,nM,T-20S138G,Enfuvirtide,HeLa,MAGI assay,19073606,Class II
LEAIPMSIPPEVKFNKAFVF,20,DB_HIV,C110 H170 N24 O26 S1,2276.75,0.998,0.00043834410000000016,6.875,53.54,0.15,97.5,0.55,-0.0398681319,0.0138976304,12720.0,nM,A17,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
DREINNYTSLIHSLIEESQNQQEKNEQELLELDKWA,36,DB_HIV,C187 H295 N53 O67,4357.68,-4.896,-0.0011235336,3.9560546875,58.7805555556,0.0555555556,89.4444444444,0.25,-0.0136427777,-0.0083242858,19.505792072846106,nM,T645,gp41,CEM,RT production,US6861059,Class I
LEAIPMSIAPEVKFNKPFVF,20,DB_HIV,C110 H170 N24 O26 S1,2276.75,0.998,0.00043834410000000016,6.875,60.84,0.15,97.5,0.55,-0.04944427,0.0124257242,16329.999999999998,nM,A9,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
YTSLIHSLIEEDQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C203 H299 N51 O64,4477.87,-4.897,-0.0010936003,3.814453125,57.3,0.1388888889,89.4444444444,0.2777777778,0.0050548228,0.0028756767,210.0,nM,T-20S138D,Enfuvirtide,HeLa,MAGI assay,19073606,Class III
YTSLIHSLIEEEQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C204 H301 N51 O64,4491.89,-4.896,-0.0010899644,3.8728027344,66.3555555556,0.1388888889,89.4444444444,0.2777777778,0.004592086400000001,0.0026619313,283.0,nM,T-20S138E,Enfuvirtide,HeLa,MAGI assay,19073606,Class III
NNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWN,36,DB_HIV,C190 H292 N52 O65,4344.68,-3.898,-0.0008971892,3.9633789063,65.5305555556,0.0833333333,89.4444444444,0.25,-0.0095687272,0.000461694,22.556321754421496,nM,T641,gp41,CEM,RT production,US6861059,Class I
RINNIPWSEAMM,12,DB_HIV,C63 H101 N19 O17 S2,1460.73,0.997,0.0006825354,6.75,54.6333333333,0.0833333333,73.3333333333,0.4166666667,0.059755102,-0.0476620216,1600.0,nM,12p1,Phage display,Cf2Th,ELISA,14967033,Class III
EMTWEEWEKKIEEYIKKIEEILKKSQNQQIDL,32,DB_JAH,C184 H293 N45 O57 S1,4079.64,-1.994,-0.0004887686,4.4118652344,68.525,0.09375,85.3125,0.25,-0.008191453000000001,-0.0050462845,0.275,nM,YIK,,MT-2,,,Class II
LIHSLIEESQNQQEKNEQELLELDKWASLWNWFNIT,36,DB_HIV,C200 H302 N52 O62,4426.87,-3.897,-0.0008803058999999998,3.9633789063,77.2138888889,0.1111111111,100.27777777780001,0.3055555556,0.0249960273,0.0041999731,2.710718860052362,nM,T637,gp41,CEM,RT production,US6861059,Class II
YTSLIHSLIEESQNQQEKNEQELLELDKWASPWNWF,36,DB_HIV,C201 H295 N51 O63,4433.82,-3.898,-0.0008791516,3.9633789063,67.4777777778,0.1388888889,78.6111111111,0.25,-0.0009207055,0.0002509858,3.15754811877794,nM,T705,gp41,CEM,RT production,US6861059,Class II
LEAIPMSIPPEVKANKPFVF,20,DB_HIV,C106 H168 N24 O26 S1,2226.69,0.998,0.0004481989,6.875,59.4,0.1,97.5,0.5,-0.0550706436,0.0061203469,4620.0,nM,A14,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
EELAKKAEELAKKAEELAKKAEELAKKAWASLWNWFLEAIPMSIPPEVKFNKPFVF,56,DB_JAH,C306 H474 N72 O80 S1,6473.56,1.008,0.0001557103,7.1875,52.825,0.125,83.9285714286,0.4464285714,0.0154415366,-0.007534659,91.0,nM,4HR-LBD-VIRIP,,MT-2,,,Class I
YTSLIHSLIEEWQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C210 H304 N52 O62,4548.99,-3.898,-0.0008568935,3.9633789063,47.775,0.1666666667,89.4444444444,0.2777777778,0.0001093278,-0.0013288467,29.0,nM,T-20S138W,Enfuvirtide,HeLa,MAGI assay,19073606,Class I
KVINPEPIVEPFMSKPFALF,20,DB_HIV,C112 H172 N24 O26 S1,2302.79,0.998,0.0004333873,6.875,64.98,0.15,92.5,0.5,0.0059340659,0.0084622302,100000.0,nM,Scr,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
AEAIPMSIPPEVKFNKPFVF,20,DB_HIV,C109 H166 N24 O26 S1,2260.71,0.998,0.0004414542,6.875,59.4,0.15,78.0,0.5,-0.044188383,0.01376791,100000.0,nM,A1,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
MTWEEWDKKIEEYTKKIEELIKKSQNQQIDL ,32,DB_JAH,C176 H280 N44 O55 S1,3924.45,-0.997,-0.00025404830000000004,4.5395507813,55.2483870968,0.0967741935,75.4838709677,0.2258064516,-0.0026351648,-0.0061293439000000005,0.6,nM,MT-WQ-IDL,,MT-2 ,,,Class II
IEESQNQQEKNEQELLELDKWASLWNWFNITNWLWL,36,DB_HIV,C211 H305 N53 O62,4576.01,-3.996,-0.0008732497999999999,3.6884765625,80.1638888889,0.1666666667,89.4444444444,0.2777777778,0.0512401081,0.010217527,22246.454880998946,nM,T632,gp41,CEM,RT production,US6861059,Class III
YTSLIHSLIEESQNQQEKNQQELLQLDKWASLWNWF,36,DB_HIV,C202 H301 N53 O61,4447.89,-1.9,-0.0004271688,4.2451171875,69.6111111111,0.1388888889,89.4444444444,0.2777777778,0.002580963,0.0015341951000000002,12.590239416892054,nM,T99,gp41,CEM,RT production,US6861059,Class I
YTSLIHSLIEESQNQQEKNEQELLELDKWASLANAA,36,DB_HIV,C180 H285 N49 O63,4143.5,-3.898,-0.0009407506,3.9633789063,55.525,0.0555555556,97.77777777780001,0.3333333333,0.0014717941,0.0004811156,24134.186074574634,nM,T229,gp41,CEM,RT production,US6861059,Class III
EESQNQQEKNEQELLELDKWASLWNWFNITNWLWLI,36,DB_HIV,C211 H305 N53 O62,4576.01,-3.996,-0.0008732497999999999,3.6884765625,67.9583333333,0.1666666667,89.4444444444,0.2777777778,0.0538611155,0.0103660151,218.53099097248474,nM,T631,gp41,CEM,RT production,US6861059,Class III
YTSLIHSLIEESQNQQEKLEQELLELDKWASLWNWF,36,DB_HIV,C204 H304 N50 O62,4448.91,-3.898,-0.0008761697,3.9633789063,60.2916666667,0.1388888889,100.27777777780001,0.3055555556,0.0033907516,0.0014817038,8.091869693925029,nM,T702,gp41,CEM,RT production,US6861059,Class II
LEAIPMSAPPEVKFNKPFVF,20,DB_HIV,C109 H166 N24 O26 S1,2260.71,0.998,0.0004414542,6.875,70.47,0.15,78.0,0.5,-0.0375761381,0.0185565881,23460.0,nM,A8,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
WEEWDKKIEEYTKKIEELIKKSEEQQKKN,29,DB_JAH,C168 H267 N43 O53,3737.19,0.005,1.33790361207217e-06,5.01953125,85.0275862069,0.1034482759,53.7931034483,0.1379310345,-0.0140697346,-0.0134852722,0.7,nM,SC29EK,,TZM-bl,,,Class II
YTSLIHSLIEELQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C205 H305 N51 O62,4475.94,-3.898,-0.0008708785,3.9633789063,61.005555555600004,0.1388888889,100.27777777780001,0.3055555556,-0.0007293819000000001,-0.0021424445,0.7,nM,T-20S138L,Enfuvirtide,HeLa,MAGI assay,19073606,Class II
YTSLIHSLIEEQQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C204 H302 N52 O63,4490.91,-3.898,-0.0008679755000000001,3.9633789063,62.65,0.1388888889,89.4444444444,0.2777777778,0.0049102177,0.0028113913,34.0,nM,T-20S138,Enfuvirtide,HeLa,MAGI assay,19073606,Class I
IRKAHCNISRADWND,15,DB_HIV,C75 H120 N28 O22 S1,1798.0,2.028,0.0011279199,8.7451171875,48.373333333299996,0.0666666667,65.3333333333,0.3333333333,-0.0054285714,-0.0304281731,50.0,nM,15D,gp120,CEMx174,QPCR,21264298,Class I
YTSLIHSLIEETQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C203 H301 N51 O63,4463.88,-3.898,-0.0008732314,3.9633789063,49.855555555600006,0.1388888889,89.4444444444,0.2777777778,0.0025965358,0.0010486611,0.9,nM,T-20S138T,Enfuvirtide,HeLa,MAGI assay,19073606,Class II
YTSLIQSLIEESQNQQEKNEQQLLELDKWASLWNWF,36,DB_HIV,C201 H301 N51 O63,4439.86,-2.998,-0.0006752465,3.7758789063,71.4277777778,0.1388888889,89.4444444444,0.2777777778,0.0048606388,0.000180776,0.9009293085818022,nM,T231,gp41,CEM,RT production,US6861059,Class II
LEAIPMSIPPEVKFNKPFVA,20,DB_HIV,C106 H168 N24 O26 S1,2226.69,0.998,0.0004481989,6.875,59.4,0.1,97.5,0.5,-0.0485149137,0.0143031552,100000.0,nM,A20,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
WQQWERQVRFLDANITKLLEEAQIQQEKNMYELQELDKNASLWNWF,46,DB_JAH,C264 H395 N71 O76 S1,5811.48,-1.996,-0.0003434581,4.2766113281,58.197826086999996,0.152173913,80.652173913,0.3260869565,0.0051854731,-0.0090696632,1.9,nM,C46-EHO,,PM1 human T cell,,,Class II
YTSLIHSLIEESQNQQEKNEQELLELDKWASLFNFF,36,DB_HIV,C198 H297 N49 O63,4371.79,-3.898,-0.0008916255999999998,3.9633789063,51.35,0.1388888889,89.4444444444,0.3333333333,0.004955665,0.002206504,0.06862177734978121,nM,T379,gp41,CEM,RT production,US6861059,Class II
NYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNW,36,DB_HIV,C197 H296 N52 O64,4416.79,-3.898,-0.0008825414,3.9633789063,62.65,0.1111111111,89.4444444444,0.25,-0.00359447,0.0009058477,3.3961315797219247,nM,T640,gp41,CEM,RT production,US6861059,Class II
MTWEEWDKKIEEYTKKIEELIKKS,24,DB_JAH,C141 H223 N33 O42 S1,3084.55,0.003,9.72589194534049e-07,4.8837890625,55.5375,0.125,65.0,0.2083333333,0.011581895900000002,0.0173232423,1.32,nM,MT-SC22,,TZM-bl,,,Class II
NQQEKNEQELLELDKWASLWNWFNITNWLWLIKIFI,36,DB_HIV,C220 H321 N53 O56,4604.24,-0.999,-0.0002169739,4.2509765625,43.486111111099994,0.19444444440000005,111.1111111111,0.3611111111,0.049740982,0.0047118037,217.1911108022171,nM,T627,gp41,CEM,RT production,US6861059,Class III
LEAIPASIPPEVKFNKPFVF,20,DB_HIV,C110 H168 N24 O26,2242.67,0.998,0.0004450053,6.875,50.83,0.15,97.5,0.5,-0.0458461538,0.0126121155,13000.0,nM,A6,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
YTSLIHSLIEEKQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C205 H306 N52 O62,4490.95,-2.898,-0.0006452978,4.2170410156,58.5166666667,0.1388888889,89.4444444444,0.2777777778,0.0067900842,0.0034995696000000003,708.0,nM,T-20S138K,Enfuvirtide,HeLa,MAGI assay,19073606,Class III
YTSLIHSLIEQSQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C202 H300 N52 O62,4448.87,-2.899,-0.0006516261,4.0803222656,65.8,0.1388888889,89.4444444444,0.2777777778,0.0033395837,0.0012461631,4.270747403273192,nM,T214,gp41,CEM,RT production,US6861059,Class II
YTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWF,36,DB_JAH,C202 H299 N51 O63,4449.86,-3.898,-0.0008759826,3.9633789063,62.65,0.1388888889,89.4444444444,0.2777777778,0.0029725091,0.0013998483,222.0,nM,DP178/T20/Enfuvirtide/ENF,,MT-2,,,Class III
REINNYTSLIHSLIEESQNQQEKNEQELLELDKWAS,36,DB_HIV,C186 H295 N53 O66,4329.67,-3.896,-0.0008998376,4.0979003906,60.875,0.0555555556,89.4444444444,0.25,-0.0156987129,-0.0049417017,1145.5838435723738,nM,T644,gp41,CEM,RT production,US6861059,Class III
SLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNI,36,DB_HIV,C199 H300 N52 O62,4412.84,-3.897,-0.0008831048,3.9633789063,77.2138888889,0.1111111111,100.27777777780001,0.3055555556,0.016693786699999998,0.0037310894,1.133057169532546,nM,T638,gp41,CEM,RT production,US6861059,Class II
LEAIPMSIPAEVKFNKPFVF,20,DB_HIV,C110 H170 N24 O26 S1,2276.75,0.998,0.00043834410000000016,6.875,50.71,0.15,97.5,0.55,-0.0472464678,0.0150966432,9720.0,nM,A10,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
QNQQEKNEQELLELDKWASLWNWFNITNWLWLIKIF,36,DB_HIV,C219 H318 N54 O57,4619.21,-0.999,-0.0002162707,4.2509765625,43.486111111099994,0.19444444440000005,100.27777777780001,0.3333333333,0.051683457800000006,0.0059068851,216.48723483019825,nM,T628,gp41,CEM,RT production,US6861059,Class III
EMTWEEWEKKIEEYTKKIEEILKKSQNQQIDL,32,DB_JAH,C182 H289 N45 O58 S1,4067.59,-1.994,-0.0004902166,4.4118652344,68.525,0.09375,73.125,0.21875,-0.0067042735,-0.0037828321,0.338,nM,HP23-E6-IDL,,MT-2,,,Class II
INNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW,36,DB_HIV,C192 H297 N51 O64,4343.74,-3.898,-0.0008973834,3.9633789063,62.1027777778,0.0833333333,100.27777777780001,0.2777777778,-0.0134082314,-0.0003786822,333.8137181323008,nM,T642,gp41,CEM,RT production,US6861059,Class III
YTSLIHSLIEEAQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C202 H299 N51 O62,4433.86,-3.898,-0.0008791437,3.9633789063,51.95,0.1388888889,92.22222222219999,0.3055555556,0.0006588273,-0.0007982866,0.6,nM,T-20S138A,Enfuvirtide,HeLa,MAGI assay,19073606,Class II
YTSLIHSLIEEYQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C208 H303 N51 O63,4525.95,-3.898,-0.0008612556,3.9633789063,51.95,0.1666666667,89.4444444444,0.2777777778,0.0016999841,0.0001998694,25.0,nM,T-20S138T,Enfuvirtide,HeLa,MAGI assay,19073606,Class I
YTSLIHSLIQESQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C202 H300 N52 O62,4448.87,-2.899,-0.0006516261,4.0803222656,46.7388888889,0.1388888889,89.4444444444,0.2777777778,0.0033885269,0.0010549225,5.1698521197517575,nM,T215,gp41,CEM,RT production,US6861059,Class II
LEAIPMSIPPEVKFNKPFAF,20,DB_HIV,C110 H168 N24 O26 S1,2274.73,0.998,0.0004387334,6.875,59.4,0.15,83.0,0.5,-0.0497645212,0.0147868227,100000.0,nM,A19,alpha1-antitrypsin,P4-CCR5,ELISA,17448989,Class III
SQNQQEKNEQELLELDKWASLWNWFNITNWLWLIKI,36,DB_HIV,C213 H314 N54 O58,4559.12,-0.999,-0.0002191212,4.2509765625,48.836111111099996,0.1666666667,100.27777777780001,0.3055555556,0.0525955824,0.006931699,219.34057449683274,nM,T629,gp41,CEM,RT production,US6861059,Class III
YTSLIHSLIEENQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C203 H300 N52 O63,4476.88,-3.898,-0.0008706957,3.9633789063,49.855555555600006,0.1388888889,89.4444444444,0.2777777778,0.0047077705,0.0027178178,19.0,nM,T-20S138N,Enfuvirtide,HeLa,MAGI assay,19073606,Class I
TSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFN,36,DB_HIV,C197 H296 N52 O63,4400.79,-3.897,-0.0008855228,3.9633789063,65.0083333333,0.1111111111,89.4444444444,0.2777777778,0.0086985539,0.002558205,4.771870505068408,nM,T639,gp41,CEM,RT production,US6861059,Class II
EWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLW,41,DB_HIV,C223 H338 N60 O75,5059.45,-5.894,-0.0011649488,3.8842773438,54.9414634146,0.0975609756,88.0487804878,0.243902439,-0.002457383,-0.006631550799999999,1.5,nM,WT,gp41,CHO-WT,Syncytia assay,22770564,Class II
WMEWDREINNYTSLIHSLIEESQNQQEKNEQELLELDKWASLWNWFNITNWLWYIK,56,DB_HIV,C330 H475 N83 O95 S1,7156.89,-4.895,-0.0006839563000000001,4.0657958983999976,55.7107142857,0.1785714286,85.3571428571,0.2678571429,0.0131431315,-0.0030415535,60.0,nM,P5,gp41,HeLa,Cell-to-cell fusion assay,18925934,Class I
WEEWDKKIEEYTKKIEELIKKSQNQQLDL,29,DB_JAH,C167 H264 N42 O52,3692.15,-0.997,-0.0002700324,4.5395507813,64.5448275862,0.1034482759,80.6896551724,0.2068965517,0.0004813665,-0.0125042735,3.7,nM,WQ-LDL,,MT-2,,,Class II
LIEESQNQQEKNEQELLELDKWASLWNWFNITNWLW,36,DB_HIV,C211 H305 N53 O62,4576.01,-3.996,-0.0008732497999999999,3.6884765625,76.7361111111,0.1666666667,89.4444444444,0.2777777778,0.046368663600000005,0.0096334826,40.646764320882156,nM,T633,gp41,CEM,RT production,US6861059,Class I
YTSLIHSLIEEFQNQQEKNEQELLELDKWASLWNWF,36,DB_HIV,C208 H303 N51 O62,4509.95,-3.898,-0.0008643111,3.9633789063,51.95,0.1666666667,89.4444444444,0.3055555556,-0.0010185921,-0.0024238932,9.4,nM,T-20S138F,Enfuvirtide,HeLa,MAGI assay,19073606,Class II
